Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 3Phase 2 3Phase 4 2Phase 1 2Phase 2/3 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1

Conditions

Polycystic Ovary Syndrome 2Metabolic Syndrome 1Hodgkin Disease 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 901Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 433Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Contraceptives, Oral × Clear all
NCT06852365 2026-06-01

COR-PCOS

University of Pennsylvania

Phase 2 Recruiting
100 enrolled

Polycystic Ovary Syndrome, Metabolic Syndrome

NCT00704912 2016-11-07

OWL-PCOS

Milton S. Hershey Medical Center

Phase 2 Completed
217 enrolled 16 charts

Polycystic Ovary Syndrome

NCT01014507 2012-06-25

PROFE

University of Cologne

Phase 2 Completed
60 enrolled
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡